About Roivant Sciences
- Industry
- Biotechnology
- Company size
- 201-500 employees
- Headquarters
- New York, New York
- Company type
- Public Company
- Company profile name
- Roivant
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology.
The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs.
In addition to our biopharmaceutical subsidiaries, we also build technology-focused Vants focused on improving the process of developing and commercializing medicines.
Company locations
151 W 42nd St, 15th Floor, New York, New York 10036, US
Viaduktstrasse 8, Basel, Basel-Stadt 4051 , CH
324 Blackwell Street, Bay 11, Suite #1160, Durham, NC 27701, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 29,314
- People linked to this company
- 264
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.